ZITHROMAX: AZITHROMYCIN FOR ORAL SUSPENSION.
AZITHROMYCIN FOR ORAL SUSPENSION. Key specifications include physical_form: POWDER, administration: ORAL, special_features: 200MG PER 5ML, 30ML AFTER RECONSTRUCTION, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-417-9966, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| administration | ORAL |
| special_features | 200MG PER 5ML, 30ML AFTER RECONSTRUCTION |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 300.000 MILLIGRAMS |
| part_name_assigned_by_controlling_agency | AZITHROMYCIN FOR ORAL SUSPENSION USP (ZITHROMAX) 200MG PER 5ML 30ML |
| american_hospital_formulary_service_classification_number | 081212 |
| NSN | 6505-01-417-9966 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | PACKAGE |
| SPECIAL FEATURES | 1 GRAM POWDER;SGL DOSE PACKET;ADULT USAGE ONLY G |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | AZITHROMYCIN FOR ORAL SUSPENSION 1GM PACKET POWDER 3S PG |
| TOTAL PRIMARY CONTAINER QUANTITY | 3 |